Clinical Study of Rezvilutamide Combined With Docetaxel Chemotherapy in the Treatment of Abiraterone-Resistant Prostate Cancer
Clinical trial NCT07112209 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07112209
- Sponsor
- Zhujiang Hospital
- Status
- ENROLLING_BY_INVITATION
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-06
- Primary completion
- 2027-06-10
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.